NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky announces it has commenced an investigation of Depomed, Inc. (“Depomed” or the “Company”) (NASDAQ:DEPO) concerning possible violations of federal securities laws.
On August 7, 2017, Depomed announced that it had received a request for information relating to the promotion of opioids from the U.S. Senate Committee on Homeland Security and Governmental Affairs, as well as from the Office of the Attorney General of Maryland and the U.S. Department of Justice. On this news, shares of Depomed fell sharply during intraday trading on August 8, 2017. To obtain additional information, go to:
or contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.